Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial. [electronic resource]
Producer: 20190812Description: 2106-2113 p. digitalISSN:- 1462-0332
- Adult
- Antirheumatic Agents -- therapeutic use
- Cyclophosphamide -- therapeutic use
- Disease Progression
- Female
- Humans
- Lung -- pathology
- Lung Diseases, Interstitial -- drug therapy
- Male
- Rituximab -- therapeutic use
- Scleroderma, Diffuse -- complications
- Severity of Illness Index
- Skin -- pathology
- Treatment Outcome
- Vital Capacity -- drug effects
- Walk Test
No physical items for this record
Publication Type: Equivalence Trial; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.